Ozivy: Anvisa aprova novo medicamento à base de semaglutida episode artwork

EPISODE · May 30, 2026 · 14 MIN

Ozivy: Anvisa aprova novo medicamento à base de semaglutida

from Saúde · host CBN

Em entrevista ao Show da Notícia, dr. Eduardo Salles, membro da Sociedade Brasileira Endocrinologia Metabologia, comenta a aprovação, pela Anvisa, de um novo medicamento à base de semaglutida no Brasil, o Ozivy. O especialista reforça que a versão aprovada no país é indicada, neste momento, para o tratamento do diabetes tipo 2, na dose de 1 mg. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published May 30, 2026

Embed this episode

Ready to play

Ozivy: Anvisa aprova novo medicamento à base de semaglutida

0:00 14:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Saúde?

This episode is 14 minutes long.

When was this Saúde episode published?

This episode was published on May 30, 2026.

Can I download this Saúde episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!